|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 371.20 INR | -1.09% |
|
-1.07% | -9.87% |
| 04/02 | Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026 | |
| 03/02 | Aarti Drugs Dec-quarter Consol Net Profit 405.4 Million Rupees | RE |
| Capitalization | 3.39TCr 37Cr 32Cr 29Cr 27Cr 51Cr 53Cr 334.37Cr 132.74Cr 1.64TCr 140.28Cr 137.4Cr 5.72TCr | P/E ratio 2026 * |
18.6x | P/E ratio 2027 * | 15x |
|---|---|---|---|---|---|
| Enterprise value | 3.39TCr 37Cr 32Cr 29Cr 27Cr 51Cr 53Cr 334.37Cr 132.74Cr 1.64TCr 140.28Cr 137.4Cr 5.72TCr | EV / Sales 2026 * |
1.3x | EV / Sales 2027 * | 1.15x |
| Free-Float |
38.16% | Yield 2026 * |
1.08% | Yield 2027 * | 1.45% |
Last Transcript: Aarti Drugs Limited
| 1 day | -1.09% | ||
| 1 week | -1.07% | ||
| Current month | -2.43% | ||
| 1 month | -5.74% | ||
| 3 months | -20.84% | ||
| 6 months | -23.96% | ||
| Current year | -9.87% |
| 1 week | 367.05 |  | 387.3 |
| 1 month | 355 | | 406.5 |
| Current year | 355 | | 415.45 |
| 1 year | 312.5 | | 574.95 |
| 3 years | 310.8 | | 645 |
| 5 years | 310.8 | | 841.4 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 78 | 01/06/2007 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 43 | 06/07/2012 |
Rushikesh Deole
CMP | Compliance Officer | - | 23/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | 01/04/2014 | |
| Director/Board Member | 62 | 01/06/2007 | |
| Chairman | 79 | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.09% | -1.07% | -3.14% | -3.13% | 37Cr | |
| +0.33% | -1.72% | +19.29% | +196.80% | 93TCr | |
| -0.45% | +1.44% | +54.82% | +49.59% | 59TCr | |
| +1.76% | +3.61% | +19.67% | +50.59% | 41TCr | |
| +0.08% | +1.01% | +20.89% | +28.94% | 37TCr | |
| +1.42% | +7.19% | +26.36% | +32.36% | 32TCr | |
| +1.08% | +4.32% | +27.98% | +55.61% | 31TCr | |
| +1.82% | -0.43% | +43.82% | +10.83% | 30TCr | |
| +1.32% | +5.11% | -45.12% | -37.51% | 22TCr | |
| +1.52% | -3.94% | +24.32% | +51.52% | 20TCr | |
| Average | +0.78% | +1.69% | +18.89% | +43.56% | 36.49TCr | |
| Weighted average by Cap. | +0.75% | +1.58% | +24.99% | +75.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.61TCr 29Cr 24Cr 22Cr 21Cr 39Cr 41Cr 257.26Cr 102.13Cr 1.26TCr 107.93Cr 105.71Cr 4.4TCr | 2.95TCr 33Cr 27Cr 25Cr 24Cr 44Cr 46Cr 290.87Cr 115.47Cr 1.42TCr 122.03Cr 119.52Cr 4.97TCr |
| Net income | 182.2Cr 2.01Cr 1.7Cr 1.55Cr 1.48Cr 2.74Cr 2.85Cr 18Cr 7.14Cr 88Cr 7.54Cr 7.39Cr 307.52Cr | 225.3Cr 2.49Cr 2.1Cr 1.91Cr 1.83Cr 3.39Cr 3.52Cr 22Cr 8.83Cr 108.8Cr 9.33Cr 9.14Cr 380.26Cr |
| Net Debt | - | - |
Employees
1,284
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 371.20 ₹ | -1.09% | 3,058 |
| 12/26/12 | 375.30 ₹ | -0.03% | 2,559 |
| 11/26/11 | 375.40 ₹ | -1.15% | 7,307 |
| 10/26/10 | 379.75 ₹ | +0.81% | 4,959 |
| 09/26/09 | 376.70 ₹ | +0.40% | 8,303 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
371.20INR
Average target price
480.00INR
Spread / Average Target
+29.31%
Annual profits - Rate of surprise
- Stock Market
- Equities
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition